Ignite Creation Date:
2024-07-17 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500182
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2021-05-20
Brief Title:
The Benefits of Hippotherapy for Patients With Parkinsons Disease of 75 Years
Sponsor:
Central Hospital Saint Quentin
Organization:
Central Hospital Saint Quentin
Study Overview
Official Title:
The Benefits of Hippotherapy for Patients With Parkinsons Disease of 75 Years of Age or More at Risk of Losing Their Independance
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EQUIDIA
Brief Summary:
There is no cure for Parkinsons disease resulting in an interest for research in this domain Non pharmacological measures remain essential specifically physical activity Hippotherapy is a nonconventional method which uses the horse in addition to standard care The goal being to improve or maintain the gains of the person through cognitive sensorial and motor stimulation with the aim of improving quality of life and maintaining independence With this in mind the researchers propose to evaluate quality of life as the main criterion using the PDQ8 scale validated for this disease The researchers hope results will lead to the coverage of the costs of non-conventional therapies such as hippotherapy by social security services
Detailed Description:
Parkinsons disease is a degenerative disorder with a prevalence of 250 patients per 1000 people in 2015 Prevalence and incidence increase progressively with age up to the age of 80 more than half of patients are over 75
There are two main types of Parkinsons disease in the elderly
1 Parkinsons disease begins late after the age of 75 and the disease may progress relatively slowly if there are no co-morbidities
2 Or Parkinsons disease has been evolving for a long time starting on average around the age of 55 and in this situation a number of difficulties arise depending on how long the disease has been present the association of motor and non-motor fluctuations the emergence of axonal signs and a decline in the severity of the disease signs and a decline in cognitive function
The therapeutic management of Parkinsons disease in the elderly must be assessed on a case-by-case basis The efficacytolerance ratio of dopaminergic treatments must be taken into account
In Alzheimers disease AD it has been shown that aerobic exercise can delay cognitive decline With this in mind the researchers would like to propose a new and original approach using equitherapy in elderly Parkinsons patients
The aim of this therapy will be to improve patients quality of life particularly in terms of well-being maintain and encourage their autonomy and promote social interaction
Equitherapy is an unconventional therapy which uses the horse as a complement to the treatment For the EQUIDIA study the researchers have suggested using the PDQ-8 score validated for this condition to evaluate quality of life as well as well-being and cognitive capacity for a group of Parkinsons patients over the age of 75 following 6 therapy sessionsTheir Parkinsons diagnosis is to be confirmed through morphological and phase contrast MRI The sessions will take place at the same interval of time following the administration of any dopaminergic medication Progress will be recorded by the hippotherapy therapist using an evaluation developed by a horse-riding instructor Sessions will be evaluated using inertia measurement devices to analyze quality of movement and the effect of specific activites with the horse
There are two main types of Parkinsons disease in the elderly
1 Parkinsons disease begins late after the age of 75 and the disease may progress relatively slowly if there are no co-morbidities
2 Or Parkinsons disease has been evolving for a long time starting on average around the age of 55 and in this situation a number of difficulties arise depending on how long the disease has been present the association of motor and non-motor fluctuations the emergence of axonal signs and a decline in the severity of the disease signs and a decline in cognitive function
The therapeutic management of Parkinsons disease in the elderly must be assessed on a case-by-case basis The efficacytolerance ratio of dopaminergic treatments must be taken into account
In Alzheimers disease AD it has been shown that aerobic exercise can delay cognitive decline With this in mind the researchers would like to propose a new and original approach using equitherapy in elderly Parkinsons patients
The aim of this therapy will be to improve patients quality of life particularly in terms of well-being maintain and encourage their autonomy and promote social interaction
Equitherapy is an unconventional therapy which uses the horse as a complement to the treatment For the EQUIDIA study the researchers have suggested using the PDQ-8 score validated for this condition to evaluate quality of life as well as well-being and cognitive capacity for a group of Parkinsons patients over the age of 75 following 6 therapy sessionsTheir Parkinsons diagnosis is to be confirmed through morphological and phase contrast MRI The sessions will take place at the same interval of time following the administration of any dopaminergic medication Progress will be recorded by the hippotherapy therapist using an evaluation developed by a horse-riding instructor Sessions will be evaluated using inertia measurement devices to analyze quality of movement and the effect of specific activites with the horse
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None